Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iSCLife 6 D759389 Cognate-Endocrine Regulatory Cells
- Development stage
- Preclinical
- Lead developer
- Sclnow Biotechnology
- Modality
- Stem Cell Therapies → Cell Therapies
01
Overview
iSCLife 6 (specifically the D759389 Cognate-Endocrine Regulatory Cells formulation) is an investigational stem cell therapy developed by Sclnow Biotechnology for the treatment of various endocrine disorders. The product is derived from umbilical cord pluripotent stem cells that have been differentiated into endocrine regulatory cells. The therapeutic intent is to restore or modulate endocrine function by providing functional cell replacement or regulatory signaling within the endocrine system. It is part of Sclnow's iSCLife 6 pipeline, which utilizes a proprietary stem cell platform (D759389) to generate tissue-specific cognate cells. While specific molecular targets are not defined, the therapy is being evaluated for its potential to treat hormonal and metabolic imbalances.
- Brand names
- iSCLife 6iSCLife6iSCLife-6
- Other names
- Cognate-Endocrine Regulatory CellsiSCLife 6 D759389 Cognate-Endocrine Regulatory CellsiSCLife6 D759389 Cognate-Endocrine Regulatory CellsiSCLife-6 D759389 Cognate-Endocrine Regulatory Cells
Beyond the preview
Go deeper on iSCLife 6 D759389 Cognate-Endocrine Regulatory Cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iSCLife 6 D759389 Cognate-Endocrine Regulatory Cells.